ERA-Net TRANSCAN-3: Minimally and non-invasive methods for early detection and/or progression of cancer ”

קרןמשרד הבריאות
מדינהIsrael
סוגResearch Grants, Partnership Activities
תאריך אחרון13/02/2017
פקולטהLife Sciences, Medicine
תיאור

This call of TRANSCAN focuses on:  “Minimally and non-invasive methods for early detection and/or progression of cancer ”

 

The call has three specific aims, and proposals must cover at least one of the specific topics listed below:

1: Risk stratification to distinguish groups by susceptibility for development or progression of cancer based on molecular biomarkers and established cancer risk factors

2: Validation of multiparametric methods, using the combination of promisingbiomarkers (genomic, proteomic, metabolomic and imaging markers) to improve our capability for early detection or progression of cancer.

3:Improve clinical evidence of the minimally invasive methods

Israeli applicants should contact Chief Scientist of the Minsitry of Health, Dr. Ami Ben -Yehuda:  ahmi.by@MOH.GOV.IL , to review and approve submission prior to application. 

Pls. note that in most cases applicants may hold only one MOH grant at any given time. Please check eligibility.

Funding: €100,000 for Israeli partner
Duration: 3 years

 

Pre proposal due date: 13.2.17
Full proposal due date:  7.6.17

 

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 26/12/2016
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>